• CBFb is not required for the emergence of nascent HSCs but is essential for a subsequent step before their release from the AGM.• RUNX1 is able to drive the emergence of nascent HSCs in the AGM in the absence of its cofactor CBFb.CBFb and RUNX1 form a DNA-binding heterodimer and are both required for hematopoietic stem cell (HSC) generation in mice. However, the exact role of CBFb in the production of HSCs remains unclear. Here, we generated and characterized 2 zebrafish cbfb null mutants. The cbfb 2/2 embryos underwent primitive hematopoiesis and developed transient erythromyeloid progenitors, but they lacked definitive hematopoiesis. Unlike runx1 mutants, in which HSCs are not formed, nascent, runx1 1 /c-myb 1 HSCs were formed in cbfb 2/2 embryos. However, the nascent HSCs were not released from the aortagonad-mesonephros (AGM) region, as evidenced by the accumulation of runx1 1 cells in the AGM that could not enter circulation. Moreover, wild-type embryos treated with an inhibitor of RUNX1-CBFb interaction, Ro5-3335, phenocopied the hematopoietic defects in cbfb 2/2 mutants, rather than those in runx1 2/2 mutants. Finally, we found that cbfb was downstream of the Notch pathway during HSC development. Our data suggest that runx1 and cbfb are required at 2 different steps during early HSC development. CBFb is not required for nascent HSC emergence but is required for the release of HSCs from AGM into circulation. Our results also indicate that RUNX1 can drive the emergence of nascent HSCs in the AGM without its heterodimeric partner CBFb. (Blood. 2014;124(1):70-78)